VH Pharma
Contract manufacturer and developer of medical devices, cosmetics and supplements, with wound-healing products under its own brands
About VH Pharma
VH Pharma a.s. develops and manufactures its own patented medical devices for acute and chronic wound healing (HemaGel, HemaCut SPRAY, BetaDerm) and skincare cosmetics, and also performs contract manufacturing of medical devices, cosmetics and dietary supplements.
Its contract manufacturing services cover product specification, formulation, development including test samples, primary and secondary packaging design, registration documentation, clinical trial support, quality assurance through release, and market launch support. Production forms include creams, gels, oils, capsules, powders, solutions and syrups, with filling, capsulation, blistering and tubing options. The company's own laboratory performs quality-control analyses under GMP-type conditions.
The company was founded in 2008 and is registered in Praha, with its seat at Jakubská 647/2 in Prague 1. It operates production sites in Rokycany and Stříbro, and the website states that its quality management follows ČSN EN ISO 9001:2016 and ČSN EN ISO 13485 ed.2:2016.
Product: Contract manufacturing and development of medical devices, cosmetics and dietary supplements; own wound-care products HemaGel, HemaCut SPRAY and BetaDerm.
Public contracts
Contracts VH Pharma signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
3 contracts with 2 buyers · 2.7M CZK
| Contracts | Value | |
|---|---|---|
| Zdravotní ústav se sídlem v Ústí nad Labem | 1 | 2.5M CZK |
| Ústav makromolekulární chemie AV ČR, v. v. i. | 2 | 216k CZK |
Open public tenders for VH Pharma →
Latest contracts
- 22 Sep 2026 for Ústav makromolekulární chemie AV ČR, v. v. i. · Objednávka: Analýza vzorků HHP · 96k CZK register
- 11 Feb 2026 for Ústav makromolekulární chemie AV ČR, v. v. i. · Objednávka: Optimalizace složení polymerů · 120k CZK register
- 15 May 2025 for Zdravotní ústav se sídlem v Ústí nad Labem · Obchodní smlouva o vymezení farmaceutických odpovědností v rámci smluvní kontroly kvality farmaceutických surovin, léčivých přípravků a zdravotnických prostředků · 2.5M CZK register
Jobs at VH Pharma
Leadership
- Bohumil Hána · Předseda představenstva (Chairman of the board)Source: business register
More biotech & pharma companies
VIDIA
In vitro diagnostic test kits and ELISA systems for human medicine and environmental testingNew on EvolcZentiva Group
Generic and branded medicines manufacturer supplying patients and healthcare systems across EuropeSalary transparentA - DIREKT
Vertically integrated biotech running synthesis, GMP pharma, supplement and cosmetics production from PragueAdalid Sciences
Lipid nanoparticle delivery technology, instruments and partnerships for pharma, biotech and CDMO gene therapy developersYoung companyAdvande Labs
Analytical testing and contract research services for pharmaceutical, biopharmaceutical, nutraceutical and veterinary companiesNew on EvolcAffiPro
Enzyme columns, HDX-MS workstation and affinity MALDI plates for protein mass spectrometry labs in life science researchNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Microsoft ClarityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- JoomlaHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.